Effect of fibrinolytic agents on experimental myocardial infarction.
Explore the source record for details and available documents.
Fibrinolysis↗
Biomedical subjects
P RUEGSEGGER
Publications and source records attributed to P RUEGSEGGER.
Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion.
Explore the source record for details and available documents.
Coronary Occlusion↗
Experimental studies: thrombolytic activity and related phenomena.
Explore the source record for details and available documents.
Fibrinolysis↗
The electrocardiogram during exercise.
Explore the source record for details and available documents.
Electrocardiography↗
Effect of fibrinolytic (plasmin) therapy on the physiopathology of myocardial infarction.
Explore the source record for details and available documents.
Cardiotonic Agents↗
The effect of fibrinolytic agents on myocardial infarction.
Explore the source record for details and available documents.
Cardiovascular Diseases↗
Detection of hepatitis carriers by serum glutamic oxalacetic transaminase activity.
Explore the source record for details and available documents.
Blood Donors↗
Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction.
Explore the source record for details and available documents.
Coronary Disease↗
Serum activity patterns of glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and lactic dehydrogenase following graded myocardial infarction in dogs.
Explore the source record for details and available documents.
Alanine Transaminase↗
Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction.
Explore the source record for details and available documents.
Aspartate Aminotransferases↗
Serum lactic dehydrogenase activity in acute transmural myocardial infarction.
Explore the source record for details and available documents.
Acute Disease↗